Welcome to the sixth edition of SPOTLIGHT: The Podcast of Clinical Endocrinology News, a series of six podcasts. This episode discusses the rate of visual impairment among people with diabetes in the United States, the prevalence of microvesicular steatosis, the risk of developing diabetes in patients with heart failurs, and the correlation of diabetes and coronary heart disease risk

Welcome to the fifth edition of SPOTLIGHT: The Podcast of Clinical Endocrinology News, a series of six podcasts. This episode discusses the association of hemoglobin A1c levels and mortality, the link between preeclampsia and reduced thyroid function during pregnancy, and women's risk level for insulin resistance and diabetes.

Welcome to the fourth edition of SPOTLIGHT: The Podcast of Clinical Endocrinology News, a series of six podcasts. This episode discusses the effect of lifestyle intervention on diabetes, the risks of bariatric surgery for superobese patiens, and the effects of a diet rich in pulses and nuts on gylecemic control

Welcome to the third edition of SPOTLIGHT: The Podcast of Clinical Endocrinology News, a series of six podcasts. This episode discusses the association of being overweight with the risk of developing thyroid cancer, the relationship of age, period and birth with rates of obesity, and the impact of hypoglycemia and hyperglycemia following acute myardial infarction.

Welcome to the second edition of SPOTLIGHT: The Podcast of Clinical Endocrinology News, a series of six podcasts. This episode discusses the revised thyroid cancer guidelines from the American Thyroid Association, the retinopathy prevalence in impaired fasting glucose, and the new European guidelines that address cardiovascular risk

Welcome to the first edition of SPOTLIGHT: The Podcast of Clinical Endocrinology News, a series of six podcasts. This episode covers a study of the association of type 2 diabetes with the resources in selected neighborhoods, a study on the correlation of ovarian volume with serum testosterone levels in patients with POS, and the Stop Atherosclerosis in Native Diabetics Study (SANDS)